Get the Stockscreener App
12.46
0.16%
0.02
After Hours:
12.48
0.02
+0.16%
Avid Bioservices Inc stock is traded at $12.46, with a volume of 1.28M.
It is up +0.16% in the last 24 hours and up +1.05% over the past month.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
See More
Previous Close:
$12.44
Open:
$12.45
24h Volume:
1.28M
Relative Volume:
0.64
Market Cap:
$796.98M
Revenue:
$139.91M
Net Income/Loss:
$-140.75M
P/E Ratio:
-5.638
EPS:
-2.21
Net Cash Flow:
$-20.85M
1W Performance:
+0.08%
1M Performance:
+1.05%
6M Performance:
+21.80%
1Y Performance:
+80.32%
1-Day Range:
$12.44
$12.47
1-Week Range:
$12.41
$12.47
52-Week Range:
$5.90
$12.48
Avid Bioservices Inc Stock (CDMO) Company Profile
Name
Avid Bioservices Inc
Sector
Industry
Phone
714.508.6100
Address
14191 MYFORD ROAD, TUSTIN, CA
Compare CDMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDMO
Avid Bioservices Inc
|
12.46 | 796.98M | 139.91M | -140.75M | -20.85M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Initiated | William Blair | Mkt Perform |
| Mar-14-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-08-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-17-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-10-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-17-19 | Initiated | Stephens | Overweight |
| Oct-16-19 | Initiated | Craig Hallum | Buy |
| Jun-28-19 | Upgrade | Janney | Neutral → Buy |
| May-09-19 | Downgrade | Janney | Buy → Neutral |
View All
Avid Bioservices Inc Stock (CDMO) Latest News
Avid Shareholders Approve Acquisition by GHO, Ampersand -January 30, 2025 at 05:59 pm EST - Marketscreener.com
Avid Bioservices Shareholders Approve $1.1B Sale - Orange County Business Journal
Avid Bioservices Approves Merger with Space Finco - TipRanks
Avid Stockholders Approve Transaction with GHO and Ampersand - GlobeNewswire
Avid Bioservices Final Act: Shareholders Green-Light $1.2B Private Takeover - StockTitan
Trend Tracker for (CDMO) - Stock Traders Daily
McGuire Investment Group LLC Has $145,000 Stock Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
JPMorgan Chase & Co. Purchases 80,308 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
JPMorgan Chase & Co. Has $1.24 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
### AVID Emerge Elementary: A New Era for Young Multilingual Learners ### - GlobeNewswire Inc.
Avid Bioservices (NASDAQ:CDMO) Shares Cross Above 200-Day Moving AverageHere's Why - MarketBeat
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand - GlobeNewswire
Avid Bioservices Urges Shareholders to Approve Premium Buyout Deal at 63.8% Above Peer Valuations - StockTitan
Avid Bioservices (CDMO) Started a Sale Process - Insider Monkey
Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis -January 21, 2025 at 08:00 am EST - Marketscreener.com
Avid Recommends Stockholders Follow Recommendations of ISS - GlobeNewswire
Proxy adviser ISS said to recommend Avid Bioservices holders vote for takeover - MSN
(CDMO) Proactive Strategies - Stock Traders Daily
Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Avid Bioservices COO Richard Richieri sells shares worth $30,714 By Investing.com - Investing.com UK
Insider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,283 Shares of Stock - MarketBeat
Avid Bioservices COO Richard Richieri sells shares worth $30,714 - Investing.com India
Barclays PLC Acquires 66,653 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Barclays PLC Boosts Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avid Bioservices, Inc. (CDMO) And Encourages Shareholders to Connect - AccessWire
Avid Bioservices (FRA:TEHN) Gross Profit : €10.7 Mil (TTM As of Oct. 2024) - GuruFocus.com
Symbol Lookup - GuruFocus.com
(CDMO) On The My Stocks Page - Stock Traders Daily
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand - GlobeNewswire
Avid Bioservices Urges Shareholder Approval of Premium Buyout Deal with 63.8% Upside - StockTitan
Avid Bioservices (NASDAQ:CDMO) Share Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc.CDMO - Business Wire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Shareholders to Learn More About the Investigation - AccessWire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, ATSG, STAF on Behalf of Shareholders - Marketscreener.com
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Avid Bioservices, Inc. (NASDAQ:CDMO) Short Interest Update - MarketBeat
CDMOAvid Bioservices, Inc. Latest Stock News & Market Updates - StockTitan
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand - The Manila Times
Avid Bioservices Provides Information to Shareholders - Marketscreener.com
Avid Bioservices Announces Expiration of Hart-Scott-Rodino - GlobeNewswire
Avid Bioservices Clears Key Regulatory Hurdle in GHO Capital, Ampersand Acquisition Deal - StockTitan
Geode Capital Management LLC Boosts Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avid Bioservices, Inc. (CDMO) And Encourages Investors to Connect - AccessWire
Trading (CDMO) With Integrated Risk Controls - Stock Traders Daily
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Barclays PLC - MarketBeat
CDMO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avid Bioservices, Inc. Is Fair to Shareholders - The Bakersfield Californian
Insider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 3,843 Shares of Stock - MarketBeat
Avid Bioservices, Inc. (NASDAQ:CDMO) CEO Nicholas Stewart Green Sells 145,911 Shares - MarketBeat
Avid Bioservices, Inc. (NASDAQ:CDMO) CFO Daniel R. Hart Sells 22,813 Shares - MarketBeat
Avid Bioservices CFO Daniel Hart sells shares worth $278,773 By Investing.com - Investing.com Australia
Avid Bioservices Inc Stock (CDMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):